FCF Grants Awarded to MD Anderson Cancer Center
Total grants: 1
- A phase I/II study of nivolumab plus 5-fluorouracil plus interferon-α2b for unresectable fibrolamellar hepatocellular carcinoma — Principal investigator(s): Sunyoung Lee, Ahmed Kaseb — 2020
This list represents the complete set of Fibrolamellar Cancer Foundation grants awarded to MD Anderson Cancer Center.